Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

“This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month’s treatment, of one dose per week,” he added. It is to be used together with a reduced ...